As we reflect back on our more than 25 years, some of our key accomplishments are:

  • Some of our key accomplishments are: Played a key role in the development of over 40 ophthalmic, dermatologic, and neurologic approved products
  • NDA Firsts: First treatment for macular degeneration, First soft drug, First and second intravitreal drug delivery system
  • Served over 400 clients in four continents on thousands of projects
  • Contributed to over 100 IND and IDE submissions
  • Organized and lead clients on scores of meetings with regulatory agencies worldwide
  • Serving as a director of a publicly traded ophthalmic pharmaceutical firm, including raising over $100 million in financing
  • Served as agent for a multi-million dollar licensing arrangement
  • Created several business plans, including one funded at over $80 million
  • Had our 225th paper accepted to a peer-reviewed journal
  • Published over 60 additional papers as medical writer, plus others as editor for non-English speakers
  • Performed 100’s of literature and patent searches, including support for patent arbitration
Dr. Novack chairing breaking news session at ASCPT
Dr. Novack speaker at the Inauguration of the 10th chancellor of the University of California, Santa Cruz